Related references
Note: Only part of the references are listed.Gold nanostructures: a class of multifunctional materials for biomedical applications
Claire M. Cobley et al.
CHEMICAL SOCIETY REVIEWS (2011)
Folding stability of amyloid-β 40 monomer is an important determinant of the nucleation kinetics in fibrillization
Chun-Lun Ni et al.
FASEB JOURNAL (2011)
Influence of Nanoparticle Size and Shape on Oligomer Formation of an Amyloidogenic Peptide
Edward P. O'Brien et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein Fibrillation
Celia Cabaleiro-Lago et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
Matthew Biancalana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Controlling Amyloid-β Peptide(1-42) Oligomerization and Toxicity by Fluorinated Nanoparticles
Ana M. Saraiva et al.
CHEMBIOCHEM (2010)
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses
Stephen Connelly et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity
Sungwook Choi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Nanoparticle-Induced Folding and Fibril Formation of Coiled-Coil-Based Model Peptides
Sara C. Wagner et al.
SMALL (2010)
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Roland Jakob-Roetne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Elodie Boisselier et al.
CHEMICAL SOCIETY REVIEWS (2009)
The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
Hozefa Amijee et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Amyloid β-Protein Assembly and Alzheimer Disease
Robin Roychaudhuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Gold Nanoparticles Can Induce the Formation of Protein-based Aggregates at Physiological pH
Dongmao Zhang et al.
NANO LETTERS (2009)
How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils
Ivonne Olmedo et al.
BIOCONJUGATE CHEMISTRY (2008)
Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size
Ganeshchandra Sonavane et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles
Celia Cabaleiro-Lago et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Blood-based neurochemical diagnosis of vascular dementia: A pilot study
Mirko Bibl et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Surface structure of amyloid-β fibrils contributes to cytotoxicity
Yuji Yoshiike et al.
BIOCHEMISTRY (2007)
Simple and rapid colorimetric biosensors based on DNA aptamer and noncrosslinking gold nanoparticle aggregation
Weian Zhao et al.
CHEMBIOCHEM (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Kinetics and thermodynamics of amyloid fibril assembly
Ronald Wetzel
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42 -: Stable trimer or tetramer formation by Aβ42
Yun-Ru Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Hilal A. Lashuel et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Molecular structure of amyloid fibrils: insights from solid-state NMR
Robert Tycko
QUARTERLY REVIEWS OF BIOPHYSICS (2006)
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis
CG Glabe et al.
NEUROLOGY (2006)
Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
S Barghorn et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Amyloid β 38, 40, and 42 species in cerebrospinal fluid:: more of the same?
NS Schoonenboom et al.
ANNALS OF NEUROLOGY (2005)
Role of nanoparticle surface charge in surface-enhanced Raman scattering
RA Alvarez-Puebla et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils
AT Petkova et al.
SCIENCE (2005)
Modulation of neurodegeneration by molecular chaperones
PJ Muchowski et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation
LM Hou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Techniques to study amyloid fibril formation in vitro
MR Nilsson
METHODS (2004)
Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β
M Hoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Fullerene inhibits β-amyloid peptide aggregation
JE Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
KN Dahlgren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, Aβ(1-40)ox and Aβ(1-42)ox
R Riek et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Share Paper
